Inmune Bio annual operating margin
2020
2021
2022
2023
2024
2025
Inmune Bio Operating Margin Growth & History (INMB)
Inmune Bio's operating margin was −94,766.00% for fiscal 2025.
View full Inmune Bio company overviewInmune Bio annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −94,766.00% | +209769.71 pp |
| 2024 | 2024-12-31 | −304,535.71% | −285347.97 pp |
| 2023 | 2023-12-31 | −19,187.74% | −12248.97 pp |
| 2022 | 2022-12-31 | −6,938.77% | +9167.86 pp |
| 2021 | 2021-12-31 | −16,106.63% | +95057.01 pp |
| 2020 | 2020-12-31 | −111,163.64% | — |
Inmune Bio quarterly operating margin
Q1.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q1.25
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q1 2025 | 2025-03-31 | −19,810.00% | −5873.04 pp |
| Q1 2024 | 2024-03-31 | −78,692.86% | −61790.23 pp |
| Q4 2023 | 2023-12-31 | −29,925.00% | −24108.51 pp |
| Q3 2023 | 2023-09-30 | −19,832.56% | −12237.66 pp |
| Q2 2023 | 2023-06-30 | −13,936.96% | +25988.04 pp |
| Q1 2023 | 2023-03-31 | −16,902.63% | −12928.40 pp |
| Q4 2022 | 2022-12-31 | −5,816.49% | −276.62 pp |
| Q3 2022 | 2022-09-30 | −7,594.90% | +56840.82 pp |
| Q2 2022 | 2022-06-30 | −39,925.00% | +73775.00 pp |
| Q1 2022 | 2022-03-31 | −3,974.23% | — |
| Q4 2021 | 2021-12-31 | −5,539.88% | — |
| Q3 2021 | 2021-09-30 | −64,435.71% | — |
| Q1 2021 | 2021-03-31 | −113,700.00% | — |
Inmune Bio operating margin trends
Over the last five reported fiscal years, Inmune Bio's operating margin increased from −111,163.64% to −94,766.00%, a change of +16397.64 percentage points. The latest reported quarter, Q1 2025, shows −19,810.00%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Inmune Bio filings at SEC.gov ↗